These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13289217)

  • 1. The possibility of total elimination of retrolental fibroplasia by oxygen restriction.
    GUY LP; LANMAN JT; DANCIS J
    Pediatrics; 1956 Feb; 17(2):247-9. PubMed ID: 13289217
    [No Abstract]   [Full Text] [Related]  

  • 2. STATEMENT on retrolental fibroplasia with reference to oxygen administration.
    J Indiana State Med Assoc; 1955 Sep; 48(9):990-3. PubMed ID: 13252275
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of oxygen weaning in retrolental fibroplasia.
    BEDROSSIAN RH; CARMICHAEL P; RITTER JA
    AMA Arch Ophthalmol; 1954 Apr; 53(4):514-8. PubMed ID: 14360882
    [No Abstract]   [Full Text] [Related]  

  • 4. The control of oxygen therapy for the prevention of retrolental fibroplasia.
    LANMAN JT
    J Pediatr; 1955 Mar; 46(3):365-8. PubMed ID: 14354596
    [No Abstract]   [Full Text] [Related]  

  • 5. The complete elimination of retrolental fibroplasia.
    BANISTER P; LOCKE JC
    Can Med Assoc J; 1957 Jan; 76(2):81-5. PubMed ID: 13383412
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of retrolental fibroplasia.
    STOW MN
    Med Ann Dist Columbia; 1960 Sep; 29():503-4. PubMed ID: 13835030
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrolental fibroplasia.
    BLODI FC; PARKE PC
    Am J Nurs; 1953 Jun; 53(6):718-20. PubMed ID: 13050660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attempted prevention of retrolental fibroplasia].
    BLIX H
    Nord Med; 1956 Jul; 56(29):1019-22. PubMed ID: 13358955
    [No Abstract]   [Full Text] [Related]  

  • 9. On prophylaxis of retrolental fibroplasia.
    GIRI DV
    Trans Ophthalmol Soc Aust; 1953; 13():152-63. PubMed ID: 13256616
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of retrolental fibroplasia.
    BLIX H
    Acta Paediatr Suppl (Upps); 1955 Jul; 44(Suppl 103):112-3. PubMed ID: 13292268
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rearing of premature infants without retrolental fibroplasia].
    GIRAUD P; FARNARIER G; ESPINAS J; COIGNET J
    Arch Fr Pediatr; 1954; 11(7):763-6. PubMed ID: 13218757
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrolental fibroplasia: a constant vigil.
    LEMASTER TR
    J Indian Med Assoc; 1961 Jul; 54():1027-9. PubMed ID: 13760720
    [No Abstract]   [Full Text] [Related]  

  • 13. A NEW opportunity-preventing blindness from retrolental fibroplasia.
    Foote FM
    Am J Public Health Nations Health; 1955 Jun; 45(6):795-7. PubMed ID: 14376714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of interstitial pneumonia and retrolental fibroplasia in premature infants].
    TOBLER W
    Ann Paediatr; 1953; 180(4-5):289-98. PubMed ID: 13065895
    [No Abstract]   [Full Text] [Related]  

  • 15. The therapeutic possibilities of carbon dioxide in the prevention of retrolental fibroplasia.
    FORTIER EG
    Am J Ophthalmol; 1954 Sep; 38(3):342-8. PubMed ID: 13188936
    [No Abstract]   [Full Text] [Related]  

  • 16. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen.
    KINSEY VE
    AMA Arch Ophthalmol; 1956 Oct; 56(4):481-543. PubMed ID: 13361620
    [No Abstract]   [Full Text] [Related]  

  • 17. New hope for controlling retrolental fibroplasia; as it looks to your state board of health.
    HUNTER AL
    Wis Med J; 1955 Oct; 54(10):513. PubMed ID: 13268023
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrolental fibroplasia; a reduction in incidence following a decrease in use of oxygen therapy for premature infants.
    PARMELEE AH; PILGER IS; AUSTIN WO
    Calif Med; 1956 Jun; 84(6):424-6. PubMed ID: 13316553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrolental fibroplasia; influence of reduced electrolyte intake on the incidence and severity of the disease.
    HEPNER R; FLETCHER MC; DESMOND MM; HUNT H; BRANDON S
    J Pediatr; 1956 Jan; 48(1):34-8. PubMed ID: 13295944
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevention of retrolental fibroplasia; the Schneider Foundation eye presentation.
    LOCKE JC
    Postgrad Med; 1956 May; 19(5):417-9. PubMed ID: 13322741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.